Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China · Delayed Price · Currency is CNY 18.30
+0.14 (0.77%)
Feb 3, 2026, 1:25 PM CST
Hybio Pharmaceutical Market Cap
Hybio Pharmaceutical has a market cap or net worth of 16.04 billion as of February 2, 2026. Its market cap has increased by 30.55% in one year.
Market Cap
16.04B
Enterprise Value
17.85B
Revenue
898.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.30
Market Cap Chart
Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 16.04B, an increase of 447.43%. That is a compound annual growth rate of 12.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 16.04B | 1.45% |
| Dec 31, 2025 | 15.81B | 38.87% |
| Dec 31, 2024 | 11.38B | -5.08% |
| Dec 29, 2023 | 11.99B | -22.75% |
| Dec 30, 2022 | 15.53B | 39.41% |
| Dec 31, 2021 | 11.14B | 88.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shandong Buchang Pharmaceuticals | 17.94B |
| Tonghua Dongbao Pharmaceutical | 17.59B |
| Shenzhen Kangtai Biological Products | 17.46B |
| Shenzhen Hepalink Pharmaceutical Group | 16.51B |
| Guangdong Zhongsheng Pharmaceutical | 16.28B |
| Zhejiang Jiuzhou Pharmaceutical | 16.08B |
| Fujian Cosunter Pharmaceutical | 15.87B |
| Shanghai Haoyuan Chemexpress | 15.87B |